It was great to catch up with Mazyar Shadman at ASCO24 – VJHemOnc
Jun 10, 2024, 16:08

It was great to catch up with Mazyar Shadman at ASCO24 – VJHemOnc

VJHemOnc shared a post on X:

“It was great to catch up with Mazyar Shadman at ASCO24 to find out if BTK inhibitors are a suitable treatment option for patients with CLL and cardiovascular comorbidities.

Click here to watch.”

Source: VJHemOnc/X